(thirdQuint)Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas.

 If subjects are eligible and wish to enroll in the study, they will begin chemotherapy treatment with Gemcitabine and Abraxane.

 After subjects have received treatment with these drugs, they will have surgery.

 Subjects will also have post treatment and follow up evaluations.

 Subjects may have 2 cycles of treatment and each cycle is 28 days.

 All subjects will be followed every 3 months for 3 years after their initial registration.

.

 Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas@highlight

This study is for adult patients with adenocarcinoma of the pancreas.

 The purpose of this research study is to evaluate the safety and effectiveness of the drugs Gemcitabine and Abraxane in the treatment of adenocarcinoma of the pancreas before surgery.

 Subjects will have screening tests to determine if he or she is eligible to participate in this study.

